Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Hsu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 19, 2019
Potential role of cannabidiol for seizure control in a patient with recurrent gliomaKristin Hsu, Emma Whitham, Ganessan Kichenadasse
The Cochrane Database of Systematic Reviews|August 17, 2013
Relaxin for preventing preterm birthEmily Bain, Emer Heatley, Kristin Hsu, et al.
Asia-Pacific Journal of Clinical Oncology|June 20, 2019
Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapyNikki Burdett, Kristin Hsu, Libo Xiong, et al.
JACC. Cardiooncology|April 22, 2026
Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art ReviewJoban Vaishnav, Dimitrios Bampatsias, Brian C Boursiquot, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 19, 2019
Potential role of cannabidiol for seizure control in a patient with recurrent gliomaKristin Hsu, Emma Whitham, Ganessan Kichenadasse
The Cochrane Database of Systematic Reviews|August 17, 2013
Relaxin for preventing preterm birthEmily Bain, Emer Heatley, Kristin Hsu, et al.
Asia-Pacific Journal of Clinical Oncology|June 20, 2019
Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapyNikki Burdett, Kristin Hsu, Libo Xiong, et al.
JACC. Cardiooncology|April 22, 2026
Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art ReviewJoban Vaishnav, Dimitrios Bampatsias, Brian C Boursiquot, et al.
Pageof 1